AS
Ankita Srivastva
About Ankita Srivastva
Data last updated:
Ankita Srivastva is a Director at Neogenix Pharmaceuticals Private Limited (since 2016). The company operates in Healthcare. Neogenix Pharmaceuticals Private Limited reported revenue of ₹33.5 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Neogenix Pharmaceuticals Private Limited U74900UP2016PTC140298 | Director | 23 Mar 2016 | 2016 | ₹33.5 Lakh (FY 2023) | Active |
Board colleagues of Ankita Srivastva
| Name | DIN | Company | Designation |
|---|---|---|---|
| Suman Singh | 08846045 | Neogenix Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankita Srivastva
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankita Srivastva
Ankita Srivastva currently holds 1 directorship: Neogenix Pharmaceuticals Private Limited (Director, since 23 Mar 2016, revenue ₹33.5 Lakh (FY 2023)).
Ankita Srivastva was first appointed on 23 Mar 2016 as Director at Neogenix Pharmaceuticals Private Limited.
The current boards of Ankita Srivastva's companies include Suman Singh (Neogenix Pharmaceuticals Private Limited).